Patents Examined by Stephen Wieder
  • Patent number: 4820634
    Abstract: Immunoassay which can be performed within a short period of time and a reagent composition for such immunoassay. The reagent composition contains complement and cells which contain quantitatively determinable substance therein. Antibody or antigen corresponding to antigen or antibody to be determined in a sample is bound on the outer surfaces of the cell membranes, which can be lysed by the complement upon activation thereof. In the immunoassay, a sample containing antigen or antibody to be determined is mixed with the reagent composition. The complement is activated by the resultant antigen-antibody complex. The cell membranes are lysed by the complex and the determinable substance in the cells is liberated from the cells. The amount of the liberated substance is determined.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: April 11, 1989
    Assignee: Tokyo Shibaura Denki Kabushiki Kaisha
    Inventor: Fumio Watanabe
  • Patent number: 4666833
    Abstract: A process for the production of a diagnostic device which is envisaged, in particular, for the detection of a pathologically increased concentration of dehydrogenases in fluids of humans, animals or plants and consists of a carrier and a substance mixture, in which, in each case with exclusion of UV radiation, the substance mixture, which has been adjusted to a pH value in the acid range, is brought into contact, in liquid form, with the carrier and the combination of carrier and substance mixture is subsequently dried and then enclosed in a packaging casing which is opaque to light of higher energy than red light. The process has the peculiarity that the dried combination of carrier and substance mixture in the packaging casing is securely sealed against entry of air and moisture. The device thus produced can be stored for a long time before use, without its ability to function being substantially changed.
    Type: Grant
    Filed: August 15, 1983
    Date of Patent: May 19, 1987
    Assignee: Medi-Pharma Vertriebsgesellschaft mbH
    Inventors: Asok K. Roy, Roland W. Steinbach
  • Patent number: 4587223
    Abstract: Method for quantitative determination of a biospecific affinity reaction in which an immunochemical compound labelled with a lanthanide chelate is used which can be detected by means of time-resolved fluorescence in which the amount of labelled compound present in the biospecific affinity reaction can be measured without the separation of free and biospecifically bound labelled compound having to be carried out.
    Type: Grant
    Filed: August 25, 1983
    Date of Patent: May 6, 1986
    Assignee: Wallac Oy
    Inventors: Erkki Soini, Ilkka Hemmila, Timo Lovgren